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 Abstract 
MSK1 and MSK2 kinases are activated downstream of the p38 and ERK1/2 MAPK kinases.  
Here we found that MSK1 and MSK2 are required to limit the production of pro-inflammatory 
cytokines in response to lipopolysaccharide (LPS) stimulation of primary macrophages.  By 
inducing transcription of the MAPK phosphatase DUSP1 and the anti-inflammatory cytokine 
interleukin-10, MSK1,2 exert multiple negative feedback mechanisms. Deficiency of MSK1 and 
MSK2 prevented binding of phosphorylated transcription factors CREB and ATF1 to the Il10 
and Dusp1 promoters.  MSK1,2 double knockout mice were hypersensitive to LPS-induced 
endotoxic shock and showed prolonged inflammation in a PMA-induced toxic contact eczema 
model.  These results establish MSK1 and MSK2 as key components of negative feedback 
mechanisms required to limit Toll-like receptor-driven inflammation. 
 
Introduction 
The innate immune system recognises pathogens via the detection of specific fungal, microbial 
or viral molecules referred to as pathogen associated molecular patterns (PAMPs).  Several 
groups of receptors for PAMPs have been described, including Toll like receptors (TLRs), NOD 
like receptors and C-type lectins that recognize distinct sets of PAMPs1-3. 
In macrophages, a major consequence of TLR activation is the production of pro-inflammatory 
cytokines including tumor necrosis factor (TNF), interleukin (IL)-1, IL-6 and IL-12.  The 
production of these cytokines is tightly controlled at the level of transcription, translation and 
secretion, and requires activation of several signalling pathways including those involving the 
transcription factor NF-κB and the MAP kinases (MAPK) ERK1/2, p38 and JNK1-3.  The p38 
pathway has attracted considerable interest as a possible target for anti-inflammatory drugs.  
Originally described as a lipopolysaccharide (LPS)-, stress- or IL-1–activated MAPK4-6, p38 is 
the cellular target of a group of pyridinyl imidazole compounds that inhibit IL-1 and TNF 
production by monocytes7.  Four p38 isoforms (p38α,  p38β,  p38γ and p38δ) have been 
described, but only p38α (http://www.signaling-gateway.org/molecule/query?afcsid=A001717) 
and p38β (http://www.signaling-gateway.org/molecule/query?afcsid=A001718) are inhibited by 
widely-used p38 inhibitors such as SB2035808.  The use of gene-targeted mice revealed that 
p38α and not p38β plays critical roles in the innate immune system9-11.  Whereas many p38 
inhibitors have been developed as potential drugs for autoimmune disease, none have progressed 
through clinical trials due to problems with toxicity.  Although it is possible that this toxicity is 
due to off target activity or inhibition of p38 outside the immune system, it is also possible that 
p38 inhibition could have unforeseen deleterious effects relating to the immune system12,13. 
In addition to their roles in promoting inflammation, TLRs can also activate negative feedback 
mechanisms and anti-inflammatory signals, which are critical in preventing excessive 
inflammation and may also play a role in the resolution of inflammation12,14.  Several MAPKs 
including p38 and ERK1/2 are required for some of these negative feedback mechanisms, and it 
is possible that some of the toxicity of p38 MAPK inhibitors could be due to the inhibition of 
these negative feedback pathways.  For instance, p38 activation results in the phosphorylation of 
TAB1, the regulatory subunit of the complex containing TAK1, a MAP kinase kinase kinase 
(MAP3K) involved in the activation of p38, JNK and NF-κB resulting in inhibition of Tak1; thus 
p38 inhibition can result in enhanced JNK and NF-κB activity15.  ERK1/2 and p38 also induce 
the transcription of DUSP1 (http://www.signaling-
gateway.org/molecule/query?afcsid=A001547) (also known as mkp-1), a MAPK phosphatase 
that dephosphorylates and thus inactivates p38 and JNK in vivo16.  Mice lacking DUSP1 exhibit 
prolonged p38 and JNK activation in response to LPS,  as well as augmented TNF production 
and increased sensitivity to endotoxic shock17-20. 
MSK1 (http://www.signaling-gateway.org/molecule/query?afcsid=A001562) and MSK2 
(http://www.signaling-gateway.org/molecule/query?afcsid=A001563) are two related kinases 
that are activated in vivo downstream of p38α and ERK1/221.  Mice that lack both MSK1 and 
MSK2 are viable and do not exhibit any obvious phenotype when maintained under specific 
pathogen free conditions22.  MSK1,2 can phosphorylate the transcription factors CREB and 
ATF1, as well as the chromatin protein histone H3, in response to mitogens and cellular 
stress22,23.  As a result, MSK1,2 are involved in the transcriptional induction of CREB-dependent 
immediate early genes24,25.  Neurons lacking MSK1 show reduced transcription of DUSP1 after 
stimulation with neurotrophins24.  If MSK1,2 also regulate DUSP1 transcription downstream of 
TLR signalling, they may play an anti-inflammatory role.  Whereas TLR-induced MSK 
activation has been demonstrated in cell lines 21, the role of MSK1,2 in inflammation in vivo has 
not previously been addressed.  We therefore used MSK1,2 double knockout mice to examine 
the role of MSKs downstream of TLR signalling both in vivo and in primary macrophages in 
vitro. 
 
Results 
MSKs in TLR-induced signaling 
TLRs activate ERK1/2 and p38 in macrophages, suggesting that TLR signalling should also 
activate MSKs.  LPS, via TLR4, activated ERK1/2 and p38α in bone marrow derived 
macrophages (BMDMs) (Fig. 1a).  LPS also activated MSK1, as judged by phosphorylation of 
Thr581, a site important for MSK1 activation21.  MSK1 activation was partially blocked by pre-
incubation of the cells with inhibitors of MEK1/2 (PD184352, which blocks ERK1/2 activation8) 
or p38 (SB203580).  A combination of both inhibitors was required to fully block MSK 
activation, indicating that both p38 and ERK1/2 contribute to TLR4-driven MSK activation (Fig. 
1a).  LPS also induced phosphorylation of CREB and histone H3.  
To determine if MSKs were responsible for TLR4-induced CREB and histone H3 
phosphorylation, we analyzed BMDMs from mice lacking MSK1 and MSK2.   Deficiency of 
both MSK1 and MSK2 did not appear to makedly affect macrophage differentiation, as 
equivalent numbers of BMDMs were obtained from double knockout and wild-type controls, 
and wild-type and double knockout BMDMs expressed the macrophage-specific marker F4/80 
and lacked the dendritic cell marker CD83 (Supplementary Fig. 1, online).  However, LPS-
driven phosphorylation of CREB and histone H3 was markedly reduced in double knockout 
BMDMs (Fig. 1b). This impaired phosphorylation was not due to an effect on upstream 
signalling, as double knockout BMDMs exhibited normal ERK1/2 and p38α phosphorylation in 
response to LPS (Fig. 1b).  Similar results were obtained using the TLR ligands LTA (TLR2), 
Pam3CSK (TLR2, 1 and 6) and CpG DNA (TLR9) (Fig. 1a,b), indicating that the activation of 
MSK is not restricted to TLR4. 
 
MSKs suppress pro-inflammatory cytokine production 
As MSKs are activated by TLRs, we next examined the role of MSKs in pro-inflammatory 
cytokines by BMDMs using a cytokine multiplex array.  Notably, MSK1,2 deficiency resulted in 
substantially elevated production of TNF, IL-6 and IL-12 (both IL-12p70 and IL-12p40) by LPS-
stimulated BMDMs (Fig. 2a). The increase in TNF was also observed by flow cytometry and 
immunoblotting for pre-TNF (Fig. 2b).  No difference in the production of the other cytokines 
(IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-9, IL-13 and IL-17) in the array was seen between wild-
type and double knockout cells (Supplementary Fig. 2, online). 
Cytokine production in macrophages is regulated at several levels, including transcription, 
mRNA stability, translation and secretion.  In the case of IL-12, MSK1,2 deficiency resulted in 
increased transcription of the genes encoding the p35 and p40 subunits at 6 and 8 hours after 
LPS stimulation (Fig. 2c). MSK1,2 deficiency exerted more moderate influence on TNF 
transcription, and influenced IL-6 transcription only after 8 hours of stimulation (Fig. 2c).  The 
effects of MSK1,2 deficiency were in marked contrast to the effect of inhibiting p38 and ERK1/2 
which, as expected, reduced TNF and IL-6 production in response to LPS (Supplementary Fig. 
3, online).  This finding would suggest that MSKs might be specifically involved in the 
activation of negative feedback pathways downstream of ERK1/2 and p38. 
 
MSKs promote Dusp1 transcription in macrophages. 
Dusp1 is an immediate early gene encoding a MAPK phosphatase that promotes the deactivation 
of p38 following LPS stimulation, and DUSP1 deficiency results in elevated TNF production 
after TLR stimulation.  In neurons, Dusp1 transcription is regulated by MSKs via the 
phosphorylation of CREB24.  Consistent with the finding that MSKs control CREB and ATF1 
phosphorylation downstream of TLRs (Fig. 1b), we found that MSKs also promote Dusp1 
transcription in macrophages.  DUSP1 mRNA was rapidly and transiently upregulated in 
response to LPS in wild-type BMDMs, and this upregulation was significantly lower in MSK1,2 
double-knockout cells (Fig. 3a).  Consistent with a role for MSK1, the transcription of Dusp1 in 
BMDMs following LPS stimulation was not greatly affected by pre-incubation with either 
PD184352 or SB203580 alone; however, a combination of both PD184352 and SB203580 was 
able to inhibit DUSP1 mRNA induction (Fig. 3b). LPS stimulation also increased DUSP1 
protein expression to a higher level in wild-type than MSK1,2 double knockout BMDMs (Fig. 
3c). 
In macrophages, DUSP1 preferentially dephoshorylates  p38 rather than ERK1/217-20.  To test 
whether the decrease in DUSP1 protein expression in MSK1,2 double knockout cells affected 
MAPK signalling, phosphorylation of ERK1/2 and p38 was quantified over an extended time 
course of LPS stimulation.  Deficiency of MSK1 and MSK2 had no effect on the time course of 
LPS-induced ERK1/2 phosphorylation (Fig. 3c,d).  In contrast, MSK1,2 deficiency resulted in a 
slower dephosphorylation of p38 relative to that observed in wild-type cells (Fig. 3c,d).  The 
partial nature of this effect likely stems from the fact that DUSP1 is not the only phosphatase for 
p38; overall, the pattern and magnitude of these results are in line with what has previously been 
reported in DUSP1-deficient macrophages17-20. 
 
MSKs drive IL-10 production 
In addition to pro-inflammatory cytokines, LPS also triggers production of the anti-inflammatory 
cytokine IL-10 in macrophages.  Previous studies implicated both ERK1/2 and p38 in IL-10 
production26; consistent with these prior findings,  DUSP1 deficiency results in increased IL-10 
production in response to LPS18.   
In our studies, IL-10 mRNA quantities increased following LPS stimulation; however the 
magnitude of IL-10 mRNA induction was significantly lower in MSK1,2 double knockout than 
wild-type BMDMs (Fig. 4a). Consistent with a role for MSKs in Il10 transcription, inhibition of 
p38 strongly inhibited LPS-mediated induction of both IL-10 mRNA expression and IL-10 
sectertion (Supplementary Fig. 4, online).  Notably, ERK1/2 inhibition caused an increase in 
IL-10 mRNA expression following LPS stimulation, suggesting that MAPK signalling can also 
influence Il10 transcription independently of MSKs (Supplementary Fig. 4, online). 
Concentrations of secreted IL-10 steadily increased over an 8 hour time course after LPS 
stimulation of wild-type BMDMs (Fig. 4b). IL-10 secretion from LPS-stimulated MSK1,2 
double knockout BMDMs was consistently lower than that released from wild-type BMDMs; 
this discrepancy was most pronounced at early time points, as by 8 hours the amount of IL-10 
released by double knockout cells reached 60% of the quantity produced by wild-type 
counterparts (Fig. 4b).   
IL-10 inhibits the production of pro-inflammatory cytokines in macrophages, via the activation 
of Jak-STAT signalling.  The importance of STAT3 in this process is highlighted by the finding 
that IL-10 does not effectively inhibit cytokine production in the absence of STAT327.    
Stimulation of BMDMs with LPS for 2 to 8 hours induces STAT3 Tyr705 phosphorylation; this 
phosphorylation is likely the result of autocrine IL-10 production as it does not occur in IL-10–
deficient mice28.  Consistent with these findings we found that STAT3 phosphorylation induced 
by either 2 or 6 hours of LPS stimulation was blocked by an IL-10–neutralizing antibody 
(Supplementary Fig. 5, online).   In line with the decreased IL-10 production from MSK1,2 
double knockout BMDMs (Fig. 4b), LPS-induced STAT3 phosphorylation was lower in 
MSK1,2 double knockout compared to wild-type BMDMs after 2 hours of LPS stimulation; 
however similar STAT3 phosphorylation was seen in the double knockouts and wild-type cells 
at 6 and 8 hours after LPS stimulation (Fig. 4c).  The effect of MSK1,2 deficiency on early LPS-
triggered STAT3 phosphorylation was not due to a role of MSKs downstream of IL-10, as 
stimulation of BMDMs with IL-10 resulted in similar amounts of STAT3 phosphorylation as 
well as induction of SOCS3 mRNA—an established target of IL-10 signaling—in MSK1,2 
double knockout and wild-type BMDMs (Supplementary Fig. 5, online). The normal STAT3 
phosphorylation observed at later time points after LPS stimulation in the MSK1,2 double 
knockout BMDMs could be explained by STAT3 phosphorylation being induced by another 
cytokine, such as IL-6, which is produced in higher amounts by the MSK1,2 double knockout 
cells (Fig. 2a).  Alternatively it could also be explained by the finding that by 8 h the double 
knockout BMDMs produced 60% of the IL-10 made by wild-type cells (Fig. 4b); perhaps this 
amount of IL-10 is sufficient to induce full STAT3 phosphorylation.  To test these hypotheses, 
we used neutralizing antibodies against IL-10 and IL-6.  IL-10– and IL-6–induced STAT3 
phosphorylation was blocked by IL-10– and IL-6–neutralizing antibodies, respectively (Fig. 4d).  
In both MSK1,2 double knockout and wild-type BMDMs the IL-10– but not the IL-6–
neutralizing antibodies blocked STAT3 phosphorylation induced by 8 hours of LPS stimulation. 
These findings suggest that the amount of IL-10 released by MSK1,2 double knockout 
macrophages is sufficient to trigger full STAT3 phosphorylation at later time points after LPS 
stimulation. 
Addition of exogenous IL-10 to macrophages inhibits the induction of pro-inflammatory 
cytokines in response to LPS27.  We therefore used an IL-10–neutralizing antibody to block the 
action of endogenous IL-10 to determine if the difference in TNF, IL-6 and IL-12 production 
between wild-type and MSK1,2 double knockout BMDMs could be explained by the lower IL-
10 production from the double knockout cells.  In the absence of the IL-10–neutralizing 
antibody, MSK1,2 double knockout BMDMs produced more TNF, IL-6 and IL-12 mRNA and 
protein than wild-type BMDMs following LPS treatment.  Addition of anti–IL-10 resulted in 
only a moderate increase in LPS-driven production of TNF, IL-6 and IL-12 in MSK1,2 double 
knockout BMDMs, but a substantial augmentation of LPS-driven IL-6 and IL-12 cytokine 
production in wild-type BMDMs (Fig. 5e,f).  TNF secretion was also increased by anti–IL-10 in 
wild-type BMDMs; however unlike IL-6 and IL-12 the increased TNF did not approach the 
quantity secreted by MSK1,2 double knockout macrophages (Fig. 5e,f).  No effect was seen 
when an isotope control antibody was used (Fig. 5e,f), and the anti–IL-10 treatment did not 
significantly affect LPS-induced IL-10 production by either wild-type or MSK1,2 double 
knockout BMDMs (Supplementary Fig. 6, online).   
To confirm the results with the IL-10–neutralizing antibody, MSK1,2 double knockout mice 
were crossed onto an IL-10–deficient background.  As expected, IL-10–deficient BMDMs 
secreted more IL-12, IL-6 and TNF than wild-type cells in response to LPS (Fig. 5g).  IL-10–
deficient and MSK1,2,IL-10 triple knockout BMDMs showed little difference in LPS-driven IL-
6 and IL-12 production (Fig. 5g).  Together these results indicate that the lower IL-10 production 
by MSK1,2 double knockout BMDMs strongly contributed to the higher IL-6 and IL-12 
production by MSK1,2 double knockout BMDMs.  In contrast to IL-6 and IL-12, TNF amounts 
produced by MSK1,2,IL-10 triple knockout BMDMs were higher than that released by IL-10–
deficient BMDMs (Fig. 5g), consistent with the IL-10–neutralizing antibody results .  Together, 
these findings indicate that MSKs regulate TNF production via IL-10–dependent and IL-10–
independent mechanisms. 
 
CREB and ATF1 in Dusp1 and Il10 transcription  
IL-10 and DUSP1 mRNA expression induced by LPS stimulation was significantly impaired in 
MSK1,2 double knockout BMDMs, suggesting that MSKs may directly control Il10 and Dusp1 
promoters.  MSKs phosphorylate CREB on Ser133 and thus increase its transcriptional activity.  
MSKs also phosphorylate ATF1, a CREB family member, on Ser63, a site with identical 
surrounding sequence to Ser133 in CREB.  As CREB and ATF1 were phosphorylated by 
MSK1,2 after LPS stimulation (Fig. 1b), we investigated the influence of CREB and ATF1 on 
Il10 and Dusp1 transcription.  Chromatin immunoprecipitation (ChIP) using an antibody that 
recognizes the phosphorylated forms of CREB and ATF1 showed that phosphorylated CREB 
and/or ATF1 were bound to the Il10 and Dusp1 promoters following LPS stimulation in wild-
type but not MSK1,2 double knockout BMDMs (Fig. 6a).   
To determine if the phosphorylation of CREB was essential for Il10 and Dusp1 transcription, 
gene targeted mice with a conditional Ser133Ala point mutation in the endogenous CREB1 gene 
crossed to a Tamoxifen-inducible Cre transgenic were examined (Supplementary Fig. 7a, 
online).  Mutation of CREB in BMDMs was induced by excision of a wild type minigene by 
addition of Tamoxifen.  In the Ser133Ala CREB BMDMs residual CREB phophorylation was 
observed in response to LPS suggesting that some cells may have escaped excision of the 
minigene (Fig. 6b).  Analysis of ERK1/2, p38 and MSK1 phosphorylation following LPS 
stimulation showed that the CREB S133A mutation did not affect the activation of these 
upstream signalling pathways (Fig. 6b).  Expression of Egr1 mRNA (a transcript established to 
be independent of MSK1 and CREB)22 as well as TNF and IL-6 mRNA, was not affected by the 
S133A mutation (Supplementary Fig. 7b, online). In contrast, expression of Nur77, a known 
CREB-regulated MSK target gene25, was reduced in S133A BMDMs (Fig. 6c).  Consistent with 
what was observed in MSK1,2 double knockout BMDMs, S133A BMDMs showed impaired 
LPS-induced expression of IL-10 mRNA; however, CREB mutation did not alter DUSP1 mRNA 
expression (Fig. 6c).   These results show that MSKs promotes Il10 transcription via the 
phosphorylation of CREB, and suggest that Dusp1 transcription may be regulated by the 
phosphorylation of ATF1 by MSKs. 
MSK1,2 influence in inflammatory models 
Intraperitoneal (i.p) injection of LPS in mice can lead to endotoxic shock and mortality.  Based 
on the effects of MSK1,2 deficiency on LPS responses in BMDMs described above, we would 
predict that MSK1,2 deficient mice would be more sensitive to LPS-induced endotoxic shock 
than wild-type mice.  To test this hypothesis, mice were given a sublethal dose of LPS, and their 
body temperature monitored over time.  A drop of 2oC in body temperature was taken as 
predictive of the development endotoxic shock and probable mortality29, and the mice were 
humanely sacrificed at this point.  Injection of LPS (2.5 mg/kg) into wild-type mice did not 
result in any substantial drop in body temperature over a 24 hour time course, and the mice did 
not exhibit any severe signs of LPS-induced toxicity.  In contrast, injection of the same amount 
of LPS into MSK1,2 double knockout mice resulted in obvious signs of LPS-induced toxicity, 
including piloerection, diarrhoea, eye inflammation, and a substantial drop in body temperature 
within 4 to 8 hours of LPS injection (Fig. 7a); all LPS-injected MSK1,2 double knockout mice 
exhibited a pathology of a severity that necessitated sacrifice during this time interval.  In similar 
experiments, mice were injected with a lower dose of LPS (1.8 mg/kg), and plasma cytokine 
concentrations were measured after 1 and 4 hours. In wild-type mice, plasma TNF 
concentrations peaked at 1 hour after stimulation, but decreased towards baseline after 4 hours.  
Interestingly, TNF concentrations 1 hour after LPS injection were approximately 7-fold higher in 
MSK1,2 double knockout mice compared to wild-type animals (Fig. 7b). In contrast to TNF, IL-
6 and IL-12 were only marginally increased in wild-type animals by 1 h, but were markedly 
elevated at the 4 hour time point.  Both IL-6 and IL-12 were significantly higher in MSK1,2 
double knockout compared to wild-type mice 4 hours following LPS injection (Fig. 7b).  Similar 
to the observations made in BMDMs, substantially lower concentrations of IL-10 were present in 
the plasma of MSK1,2 double knockout mice compared to wild-type mice following LPS 
injection (Fig. 7b).  No difference in plasma concentrations of IL-1α, IL-1β, IL-2, IL-3, IL-4, 
IL-5, IL-9, IL-13 and IL-17 were seen between wild-type and MSK1,2 double knockout mice 
(Supplementary Fig. 8, online).  Together these results show that MSK deficiency increases 
sensitivity of mice to LPS-induced endotoxic shock, and these findings correlate with the 
elevated TNF, IL-6 and IL-12 and decreased IL-10 amounts in MSK1,2 double knockout mice. 
Whereas i.p. injection of LPS has some similarities to septic shock, clinical sepsis is a much 
more complex condition and several major differences between the two conditions have been 
described30.  As the cecal ligation and puncture (CLP) model shows more similarities to septic 
shock in humans30, the effect of MSK1,2 deficiency was also examined in this system. In these 
experiments, wild-type and double knockout mice showed similar mortality or morbity within 8 
hours of CLP (6/10 double knockout and 5/10 WT died).  However, after 48 hours, all remaining 
double knockout mice, but only 1 wild-type mouse survived (Fig. 7c).  In a separate experiment, 
plasma cytokine concentrations were measured at 1 and 4 hours after CLP.  In contrast to i.p. 
LPS injection, CLP induced little expression of TNF at this time point.  Similarly, IL-12 
expression increased only 4 to 6 fold and was not markedly affected by knockout of MSK1 and 
MSK2 (Fig. 7d).   IL-6 was strongly induced by CLP, but also was not substantially affected by 
MSK1,2 deficiency (Fig. 7d).  IL-10 was also induced by CLP in wild-type animals and, 
consistent with the i.p. LPS model, double knockout animals expressed less IL-10 (Fig. 7d). 
The consequence of MSK1,2 deficiency was also examined in an acute PMA-induced toxic 
contact eczema model.  In this model local inflammation is induced in the ear by topical 
administration of PMA.  In wild-type mice, this localized inflammation results in an increase in 
ear thickness, which normally peaks at 8 hours and then slowly resolves (Fig. 8a).  In MSK1,2 
double knockout mice the inflammation failed to resolve, and no substantial reduction in ear 
thickness was seen even by 96 hours after PMA treatment (Fig. 8a).  The extent of neutrophil 
recruitment was estimated using an MPO (myeloperoxidase) assay on extracts from ear biopsies.  
Consistent with the lack of resolution of ear thickness, MPO activity was significantly increased 
in the MSK1,2 double knockout compared to wild-type animals, at both 72 and 96 hours after 
PMA treatment (Fig. 8b).  Histological analysis of the inflamed tissue confirmed an increased 
cellular infiltration in the dermis, as well as an increased total ear and epidermal thickness, in 
MSK1,2 double knockout compared to wild-type animals (Fig. 8c).  
These results suggest that MSK have a protective role in acute endotoxic shock and toxic contact 
eczema, but may have a deleterious function in sepsis. 
Discussion 
Although ERK1/2 and p38 have previously been shown to play important roles in pro-
inflammatory cytokine production and inflammation, it is now becoming apparent that these 
MAP kinases also activate negative feedback pathways that are critical for preventing 
uncontrolled inflammation.  This negative feedback occurs through both intracellular 
mechanisms and via the release of anti-inflammatory cytokines.  For instance, p38 is able to 
inhibit the MAP3K TAK1 via phosphorylation of the regulatory subunit TAB115, whereas both 
ERK1/2 and p38 can induce the expression of DUSP1 that promotes the inactivation of p38 and 
JNK17-20.  In addition, both ERK and p38 promote expression of tristetraprolin (TTP), which 
induces degradation of TNF mRNA31.   TLR signalling also induces the production of IL-10, an 
anti-inflammatory cytokine known to inhibit pro-inflammatory cytokine production by 
macrophages27. 
Here we show that the ERK1/2- and p38- activated kinases MSK1 and MSK2 utilize multiple 
mechanisms to limit the pro-inflammatory effect of TLR4 signalling.  Knockout of MSK1 and 
MSK2 resulted in decreased expression of  DUSP1.  The Dusp1 promoter contains a conserved 
CREB-binding site32, Dusp1 is a CREB-dependent immediate early gene in neurons24, and 
knockout of MSK1 blocks CREB phosphorylation and Dusp1 transcription in response to  brain-
derived neurotrophic factor (BDNF) in cortical neurons.   Using ChIP analysis, we found that 
phosphorylated CREB and/or ATF1 binds to the Dusp1 promoter following LPS stimulation in 
BMDMs, in a manner dependent on MSK activity.  Notably, phosphorylation of CREB on 
Ser133 was not essential for Dusp1 transcription in response to LPS; this observation suggests 
that MSK1,2 regulate the Dusp1 promoter via the phosphorylation of ATF1, or by an 
undescribed mechanism.   
Similar to MSK1,2 double knockout mice, DUSP1-deficient mice do not show an obvious 
phenotype in the absence of LPS challenge, but like MSK1,2 double knockouts, DUSP1-
knockouts do show  increased susceptibility to LPS-induced endotoxic shock17-20.  Whereas the 
phenotype of the DUSP1-deficient and MSK1,2-deficient animals are similar, the reduction in 
DUSP1 expression alone is unlikely to explain all the effects seen in the MSK1,2 double 
knockout animals.  A major difference between the two animal models is in the expression of IL-
10, which is decreased in MSK1,2 double knockout but increased in DUSP1-deficient mice. As 
LPS-induced IL-10 production was reduced by inhibition of p38, the elevated IL-10 
concentrations in the DUSP1 knockouts are consistent with the prolonged p38 activation in these 
mice.  In contrast, the reduction of LPS-induced IL-10 transcription in the MSK1,2 double 
knockouts, together with the lack of reduction in ERK1/2 and p38 activation, suggests that 
MSKs may directly regulate the transcription of IL-10.  Consistent with this, two MSK 
substrates, CREB and histone H3, have been proposed to be involved in Il10 transcription26,33-35.  
In BMDMs, MSKs were required for binding of phosphorylated CREB and/or ATF1 to the Il10 
promoter following LPS stimulation, and that mutation of the Ser133 phosphorylation site in 
endogenous CREB reduced Il10 transcription in response to LPS.  
MSK1,2 deficiency also resulted in elevated production of TNF, IL-6 and IL-12 at later time 
points after LPS stimulation.  As MSK1,2 double knockout and wild-type cells produced similar 
amounts of IL-6 and IL-12 in the presence of an IL-10–neutralizing antibody, and as MSK1,2 
deficiency had little effect on IL-6 and IL-12 production on an IL-10–deficient background, 
MSK1,2 seem to regulate IL-6 and IL-12 via an autocrine inhibition loop involving IL-10.  In 
contrast, augmented TNF production in MSK1,2 double knockouts seems to be the result of IL-
10-dependent and independent mechanisms.  Increased p38 activation, due to the reduction in  
DUSP1 expression, may be involved.  In addition, MSK-mediated regulation of the transcription 
of TTP, an mRNA binding protein that destabilises TNF mRNA, might play a role31.   
The role of MSK was not limited to BMDMs, as similar results were obtained in in vivo models 
of endotoxic shock and eczema where MSK1,2 deficiency resulted in increased inflammation. 
MSK1,2 double knockouts, however, did not show an increased sensitivity in the CLP model.  
This may be due to CLP being a more acute model than the i.p. Injection of a low dose LPS 
making it more difficult to observe an increase in sensitivity.  Surprisingly while there was a 
similar mortality in the wild type and knockout mice before excision of the caceum, after 
excision no mortality occurred in the knockout animals while all but one of the remaining wild 
type animals were terminated.  This suggests that MSK knockout could be protective in sepsis, 
but deleterious in acute endotoxic shock.  Many differences have been described between these 
two models, making it difficult to directly extrapolate findings from one model to the other.  In 
contrast to i.p. LPS injection, CLP induces a bacterial peritonitis that activates a wider range of 
immune pathways and involves both inflammatory and immunosuppressive stages 30.  Relevant 
to this it has been shown that CLP is not affected by loss of TLR4 (the receptor for LPS), 
indicating that several PAMPs are important in this model36,37.  The role of cytokines in the two 
models is also different, for instance TNF blockade is protective following LPS injection but not 
in CPL38.  In fact endogenous TNF has been suggested to have protective effects under some 
circumstances in CLP; TNF neutralising antibodies have a harmfull effect if administered 
immediately after CLP39, and TNF-Receptor1 knockout mice show higher mortality in a CLP 
model40. 
The role of IL-10 is also complex. Neutralisation of IL-10 with antibodies prior to induction of 
CLP41 or IL-10 knockout42 increases mortality in CLP.  In contrast, blocking IL-10 after the 
induction of CLP (a situation more similar to what would occur in the MSK1,2 double 
knockout), either by neutralising antibodies43 or inhibition of IL-10 transcription44 had a 
protective effect.  In addition, high IL-10 levels have been correlated with poor outcome in 
clinical sepsis45. 
IL-12 is another cytokine that was increased in MSK knockouts following LPS stimulation.  IL-
12 knockout mice46 or IL-12 neutralising antibodies47 both sensitise mice to mortality in CLP. 
One possible explanation for the CPL results in the MSK knockout mice is that MSK has an 
immunosuppressive effect that may reduce bacterial clearance resulting in increased peritonitis.    
Together these results establish the critical role played by MSK1,2 in limiting pro-inflammatory 
signalling downstream of TLRs.  It is possible that some of the toxicity associated with p38 
inhibitors could be due to the inhibition of MSK1,2-mediated negative feedback mechanisms.  
Thus, agents that selectively activate MSK1,2 may have therapeutic benefits in situations where 
increased IL-10 and reduced pro-inflammatory cytokine production is desired. 
Methods 
Animals 
Mice lacking MSK1 and MSK2 have been described previously22.  IL-10–deficient mice48 on a 
C57/Bl6 background were obtained from the Jackson Labs.  An inducible S133A mutation in the 
endogenous CREB gene was generated via the insertion of a floxed minigene (Supplementary 
Fig. 7, online) and will be reported elsewhere. To allow the generation the CREB knockin 
mutation in BMDMs, these mice were crossed onto a Tamoxifen inducible CRE strain.  The 
Tamoxifen inducible CRE transgene was found to have no effect on LPS induced CREB 
phosphorylation or cytokine transcription (Supplementary Fig. 9, online)All strains were 
backcrossed on to C57Bl6 for a minimum of 6 generations.  Mice were housed under specific 
pathogen-free condition in accordance with EU regulations.  Work was approved by local ethical 
review and carried out under either a UK Home Office project licence (in vivo LPS injection) or 
were approved by the Danish Laboratory Animal Research committee (Dyreforsøgstilsynet) (j/nr 
2005/561-963) (CLP, Acute toxic contact eczema). 
Cell culture 
BMDMs were isolated from the femurs of adult mice as described previously10.  BM cells were 
differentiated on bacterial grade plastic dishes for 7 days in DMEM supplemented with 10% 
FBS, 100 units/ml Penicillin, 100 μg/ml Streptomycin, 0.25 μg/ml Amphothericin B, 5 mg/ml L-
Glutamine, and 5 ng/ml M-CSF (R&D).  Where appropriate, the CREB S133A mutation was 
induced by the addition of 0.1 μM Tamoxifen on day 5 of cultures.  After 7 days adherent cells 
were removed using Versene solution (Gibco), counted and re-plated at constant density (2 × 105 
cells/ml). Cells were stimulated for the indicated times 24 to 48 h after re-plating using either 
100 ng/ml LPS (Sigma), of Pam3CSK4 (1 μg/ml), LTA-SA (5 μg/ml) or CpG DNA (ODN1826, 
2.5 μM), all from InvivoGen.   For experiments using kinase inhibitors, either PD184352 (2 
μM/ml) or SB203580 (5 μM/ml) were added to the culture media 1 hour before stimulation. For 
immunoblotting cells were lysed directly into 1% (w/v) SDS sample buffer.  For RNA, cells 
were lysed in an RNA lysis buffer (Qiagen) and RNA isolated using Qiagen RNAeasy®  
Microkit. 
In vivo LPS injection 
Mice (6-8 weeks old) were injected with LPS (Sigma, 1.8 mg/kg) intraperitoneally (i.p.). Mice 
were sacrificed one hour or four hours after the LPS injection and plasma samples were collected 
for cytokine analysis. 
Cecal ligation and puncture  
Mice (7-8 weeks old) were starved for 16 h and cecum was ligated just below the ileocecal valve 
maintaining bowel continuity49.  The cecum was punctured at both ends using a 21G needle and 
a single droplet of fecal material was extruded from each puncture site.  The abdomen was 
closed in two layers, resuscitated subcutaneously with 3 ml/100 g BW saline, a microchip 
inserted subcutaneously on the back of the mouse and the animal returned to its cage; this was 
taken as time 0 for subsequent measurements.  After 10 hours, the cecum was excised and the 
abdominal cavity irrigated with warm saline.  The abdominal cavity was closed and animals 
resuscitated subcutaneously with 3 ml/100 g BW saline.  A blood sample was taken after 6 
hours, and animals were resuscitated subcutaneously with 3 ml/100 g BW saline every 10 hours.   
The temperature of the mice was measured at the indicated time points.  If a drop in body 
temperature below 30oC was observed in a moribund animal, or if a prolonged drop below 30oC 
was observed for several hours, the animals were humanely sacrificed.  In a similar experiment, 
100 μl of blood was taken at 1 h, followed by termination of the animal at 4 h allowing a further 
blood sample to be taken.  Plasma cytokine levels were then measured in the blood samples 
using Luminex assays.  The CLP model was performed by Pipeline biotech A/S. 
LPS-induced endotoxic shock 
Mice (10-12 weeks old) were anaesthetised and temperature sensors were surgically implanted 
into the peritoneal cavity. 14 days later mice were challenged with 2.5 mg/kg of LPS (Sigma), 
i.p. Temperatures of mice were monitored constantly after the LPS injection using Remo 400 
detection system. A drop in the temperature of more than 1.5-2°C compared to the average 
diurnal temperature was used as an indicative of LPS-induced death and the mice were 
sacrificed.  
Acute toxic contact eczema model 
Mice (6-8 week old males) were treated with phorbol 12-myristate 13-acetate (PMA) (Sigma) on 
the ears (2.5 µg/ear). Ear thickness was measured before the first challenge of PMA and again 
post-challenge at the times indicated, using a Mitutyo digimatic indicator. The mice were 
anaesthetized during the ear measurement.  
Myeloperoxidase (MPO) assay 
Four mm punch biopsies were taken from the ears of the mice 72 and 96 h after PMA challenge 
and immediately placed in liquid nitrogen. The MPO assay was carried out as previously 
described50. Briefly, the biopsies were homogenised in 200 µl 0.5% 
hexadecyltrimethylammonium bromide (HTAB). Samples were incubated at 37°C for 1 hour and 
then centrifuged for 5 min. MPO activity was assayed in the supernatant as follows; 20 μl of the 
supernatant was added to 96-well plates containing 100 μl of TMB ONE, Ready-to-use Substrate 
(Kem-En-Tec Diagnostics A/S). After 10 min incubation in the dark at room temperature the 
reaction was stopped by adding 100 μl 0.2 M H2SO4. Results were determined by an ELISA 
reader (Laboratory Systems iEMS Reader MF) at 450 nm. A standard curve was constructed 
with polymorphonuclear human cells (PMNs) obtained from blood from healthy human 
volunteers. PNMMNs were prepared using PolymorphprepTM (AXIS-SHIELD PoC AS) 
according to the manufacturer’s instructions. These experiments were approved by the local 
ethical commitee of Aarhus and undersigned informed consent was obtained from the 
volunteers. 
Other methods 
Details of antibodies, chromatin immunoprecipitation, quantative PCR, cytokine assay, FACS 
and histology are provided in the supplementary methods online. 
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Figure 1  MSK is activated by TLR signalling 
A) Wild-type BMDMs were pre-incubated for 1 h with PD184352 (2 μM), SB203580 (5 
μM) or a combination of both inhibitors as indicated, and were then stimulated for 30 
min with either LPS (100 ng/ml), Pam3CSK4 (Pam, 1 μg/ml), LTA-SA (LTA, 5 μg/ml) 
or CpG DNA (2.5 μM).  Cells were lysed in SDS sample buffer and immunoblotted for 
p-MSK1(Thr581), p-CREB(Ser133), p-Histone H3(Ser10), p-ERK1/2, p-p38 and total 
p38.  Results are representative of three independent experiments. 
B) BMDMs were isolated from wild-type (WT) and MSK1,2 double knockout (KO) mice 
and were stimulated with LPS (100 ng/ml), Pam3CSK4 (Pam, 1 μg/ml), LTA-SA (LTA, 
5 μg/ml) or CpG DNA (2.5 μM) for 15 or 30 min as indicated, then lysed and 
immunoblotted as in (a). Results are representative of three independent experiments. 
 
Figure 2 MSK1,2 deficiency results in elevated pro-inflammatory cytokine production in 
response to LPS. 
A) BMDMs from either wild-type (WT) or MSK1,2 double knockout (KO) mice were 
stimulated with 100 ng/ml of LPS.  Samples of the culture media were taken at 0, 4 and 
12 h of stimulation, and concentrations of TNF, IL-6, IL-12p40 and IL-12p70 were 
measured by a Luminex-based assay.  Error bars represent the s.e.m of stimulations on 
independent cultures from 3 animals. 
B) BMDMs from wild-type (WT) or MSK1,2 double knockout (KO) mice were stimulated 
with 100 ng/ml of LPS for the indicated times, and cells were lysed in SDS sample 
buffer. Cellular pre-TNF was measured by immunoblotting; total ERK1/2 is shown as a 
loading control.  Plasma membrane-bound (extracellular) and intracellular TNF were 
measured by flow cytometry. WT BMDM, grey shaded histogram; MSK1,2 double 
knockout, black lines.  Results are representative of at least three independent 
experiments. 
C) BMDMs from either wild-type or MSK1,2 double knockout mice were stimulated with 
100 ng/ml of LPS for the indicated times.  Total RNA was then isolated and indicated 
transcripts were analyzed by qPCR.  Samples were corrected for expression of 18s RNA 
and fold induction calculated relative to the wild-type 0 h time point.  Error bars 
represent the s.e.m of stimulations on independent cultures from 3 animals. 
 
Figure 3 MSKs regulate Dusp1 transcription in macrophages. 
A) BMDMs were isolated from wild-type (WT) and MSK1,2 double knockout (KO) mice.  
Cells were stimulated for the indicated times with 100 ng/ml of LPS.  Total RNA was 
then isolated and DUSP1 mRNA expression analysed by qPCR.  Results are corrected for 
18s RNA expression and fold stimulation calculated relative to the wild-type 0 h time 
point.  Error bars represent the s.e.m of stimulations on independent cultures from 3 
animals. 
B) Wild-type BMDMs were pre-incubated for 1 h with either PD184352 (2 μM), SB203580 
(5 μM) or a combination of both inhibitors as indicated.  Cells were then stimulated for 
60 min with 100 ng/ml of LPS.  Total RNA was isolated and DUSP1 mRNA expression 
was analysed by qPCR.  Results are corrected for 18s RNA expression, and error bars 
represent the s.e.m of stimulations on independent cultures from 3 animals. 
C) BMDMs from either wild-type or MSK1,2 double knockout mice were stimulated with 
LPS for the indicated times.  Cells were lysed and immunoblotted for DUSP1, p-p38, 
total p38, p-ERK1/2 and total ERK1/2.  Results are representative of 6 independent 
stimulations. 
D) p-p38 and p-ERK1/2 immunoblots in (c) were quantified and corrected for total p38 and 
total ERK1/2, respectively, using the LI-CORR Odyssey detection system. Fold 
induction was calculated relative to the wild-type 0 h time point and error bars represent 
the s.e.m of six independent stimulations.  *P < 0.05, **P < 0.01, wild-type versus 
MSK1,2 double knockout. 
 Figure 4 MSK regulates LPS-induced IL-10 production 
A) BMDMs from wild-type (WT) and MSK1,2 double knockout (KO) mice were stimulated 
with 100 ng/ml of LPS for the indicated times. Total mRNA was isolated and IL-10 
mRNA measured by qPCR. Samples were corrected for expression of 18s RNA and fold 
induction calculated relative to the wild-type 0 h time point.  Error bars represent the 
s.e.m of stimulations on independent cultures from 3 animals. 
B) As in (a), but concentrations of secreted IL-10 were measured by a Luminex-based assay. 
Error bars represent the s.e.m of stimulations on independent cultures from 3 animals. 
C) BMDMs from wild-type (WT) or MSK1,2 double knockout (KO) mice were stimulated 
with 100 ng/ml of LPS for the indicated times and lysed in SDS sample buffer.  p-
STAT3(Tyr705), total STAT3, GAPDH and actin were measured using the LI-CORR 
Odyssey detection system.  Bottom, representative immunoblots; top, quantification 
relative to an average of the GAPDH and actin loading controls.  Error bars represent the 
s.e.m of stimulations on independent cultures from 3 animals. 
D) BMDMs from wild-type or MSK1,2 double knockout mice were cultured and where 
indicated pre-treated for 15 min with either IL-10 or IL-6 neutralizing antibodies (2.5 
μg/ml).  Cells were then stimulated with either LPS (100 ng/ml, 8h), rmIL-10 (10 ng/ml, 
30min) or rmIL-6 (10 ng/ml, 30min).  Cells were then lysed and immunoblotted for p-
STAT3(Tyr705) and total STAT3. 
 
Figure 4 MSK induced IL-10 production inhibits IL-6 and IL-12 production. 
A) BMDMs were pre-treated for 15 min with anti–IL-10 (2.5 μg/ml) or rat IgG (2.5 μg/ml) 
where indicated. Cells were stimulated with 100 ng/ml of LPS for 8 h.  Cytokine 
concentrations in the media were measured by a Luminex-based assay. Error bars 
represent the s.e.m of stimulations on independent cultures from 3 animals. 
B) As in (e) except total mRNA was isolated and indicated transcripts measured by qPCR. 
Samples were corrected for expression of 18s RNA and fold induction calculated relative 
to the wild-type 0 h time point.  Error bars represent the s.e.m of stimulations on 
independent cultures from 3 animals. 
C) BMDMs from wild-type, IL-10-deficient and MSK1,2,IL-10 triple knockout mice.  Cells 
were stimulated with 100 ng/ml LPS and secreted cytokines were measured by a 
Luminex-based assay. 
 
Figure 6 Il10 and Dusp1 promoters associate with p-CREB and/or p-ATF1. 
A) Wild-type or MSK1,2 double knockout BMDMs were stimulated with 100 ng/ml LPS where 
indicated.  Cells were fixed in formaldehyde and the chromatin fraction isolated.  An antibody 
which recognizes p-CREB and p-ATF1 was used to immunoprecipitate chromatin.  Input and 
immunoprecipitated chromatin was analysed by PCR using primers specific for the indicated 
promoters. 
B) BMDMs isolated from control and CREB S133A mice were treated with 0.1 μM Tamoxifen 
from day 5 to 7 of differentiation.  Macrophages were then replated in Tamoxifen-free media and 
used 24 h later.  Cells were stimulated for the indicated times with 100 ng/ml LPS, lysed and  
analyzed by immunoblotting.  
C) As in (b) except total RNA was isolated and indicated transcripts were measured by qPCR. 
18s RNA was used as a loading control and fold stimulation calculated relative to wild-type 
control values.  Error bars represent the s.e.m of 4 stimulations. 
 
 
Figure 7 MSK1/2 in sensitivity to inflammation in vivo 
A) Mice were implanted with a remote temperature sensor to allow continuous monitoring 
of body temperature.  Two weeks later mice were injected i.p. with LPS (2.5 mg/kg) and 
their temperature recorded over time.  Mice that showed a drop of approximately 2°C 
below average diurnal temperature were sacrificed.  Wild-type mice (n=6), MSK1,2 
double knockout (n=5). 
B) Wild-type (WT) and MSK1,2 double knockout (KO) mice were given an i.p. injection of 
either saline (control) or 1.8 mg/kg of LPS.  Mice were sacrificed 1 or 4 h after injection 
and blood taken by cardiac puncture.  Plasma cytokines were measured by a Luminex-
based assay.  Error bars represent the s.e.m of 6 mice. 
C) Mice were subjected to cecal ligation and puncture or sham treated as described in the 
methods.  Survival of mice was measured at the indicated times. Wild-type (n=10), 
MSK1,2 double knockout (n=10), sham (n=5).  Animals were terminated if they were 
either moribound with a body temperature of 30oC or if their temperature remained 
below 30oC for 2 h.  
D) Wild-type or MSK1,2 double knockout animals were subject to cecal ligation and 
puncture or shame treatment. Blood samples were taken at 1 and 4 hours, and plasma 
cytokine concentrations determined as described in the methods. MSK1,2 double 
knockouts (n=7), wild-type (n=7), sham (n=4).  Error bars represent s.e.m. 
 
 
Figure 8  MSK1,2 in sensitivity to PMA-induced eczema 
A) Wild-type (WT) and MSK1,2 double knockout (KO) mice were treated with PMA (2.5 
µg/ear) or vehicle (acetone) on the ears. Ear thickness was recorded over time. PMA- 
treated wild-type mice (n=12), PMA-treated MSK1,2 double knockout (n=12), vehicle-
treated wild-type mice (n=8), and vehicle-treated MSK1,2 double knockout (n=8). 
Results are presented as mean ± s.e.m. 
B) PMA (2.5 µg/ear) was applied to the ears of wild-type and MSK1,2 double knockout 
mice for the indicated time periods. 4 mm punch biopsies were taken from the ears and 
analysed for MPO activity (neutrophils (×103)/4 mm punch biopsy). PMA-treated wild-
type mice (n=12), PMA-treated MSK1,2 double knockout mice (n=12), vehicle-treated 
wild-type mice (n=8), and vehicle-treated MSK1,2 double knockout mice (n=8). Results 
are shown as mean ± s.e.m. 
C) Haematoxylin and eosin-stained histological sections of wild-type and MSK1,2 double 
knockout mice treated with PMA (2.5 µg/ear) or vehicle for 72 h and 96 h. Scale bar = 
100 µm. Representative transversal sections of vehicle-treated (n= 4) and PMA-treated 
(n=8) ears. 








Supplementary methods 
Antibodies 
Anti-ERK1/2, anti-p-ERK1/2, anti-p38 anti-p-MSK1 (Thr581) and anti-p-MSK2 
polyclonal were from Cell Signalling and the anti-p-Histone H3(Ser10) antibody was 
from Upstate.  The monoclonal anti-p-CREB(Ser133) (clone 10E9) was from Upstate. 
Rat anti-mouse IL-10R was kindly provided by Ann O’Garra (National Institute of 
Medical Research, London).  The polyclonal anti-PreTNF and anti–IL-6 antibodies 
were from R&D Systems (AF-410-NA; AF-406-NA).  Antibodies for FACS analysis 
(anti-TNF-PE clone MP6-XT22, anti-F4/80-FITC clone BM8 and anti-CD83-PE 
clone Michel-19) were purchased from Serotec and BD Pharmingen, respectively.  
 
Real-time PCR 
Total RNA (0.5 µg) was reverse-transcribed using iSCRIPT cDNA synthesis kit (Bio-
Rad).  Real-time PCR was carried out using SYBRgreen detection kit (Bio-Rad) 
according to manufacturer’s instructions.  Fold changes in mRNA expression were 
quantified relative to unstimulated wild-type cells, and 18S RNA was used as a 
loading control as described1.  Sequences for the primers  are listed in 
Supplementary Table 1. 
 
Multiplex cytokine assay 
Cytokine concentrations in cell supernatants and mouse plasma samples were 
detected using either Luminex-based Bio-Plex TM Mouse Grp I Cytokine 23-Plex 
Panel (Bio-Rad) or individual Bioplex cytokine kits. 
 
 
FACS 
BMDMs were stimulated with 100 ng/ml LPS for the indicated times and stained with 
anti-F4/80-FITC and anti-TNF-PE antibodies. For detection of intracellular TNF cells 
were stained using BD Cytofix/CytopermTM Plus Fixation/Permeabilization Kit with 
BD GolgiPlug TM. Prior to detection of extracellular TNF cells were pre-treated for 6 
h with 1 µg/ml TACE inhibitor (Calbiochem).  
 
Histology 
Skin samples were fixed in 4% formaldehyde, embedded in paraffin, and processed 
for histological analysis.  Sections were cut at 4 µm, mounted onto slides, and stained 
with haematoxylin and eosin according to standard procedures.  
 
Chromatin immunoprecipitation (ChIP) 
Cells were fixed with formaldehyde, and chromatin was isolated and subjected to 
mechanical sheering and immunoprecipitation as described2. Anti-p-CREB (R&D 
Systems) was used to immunoprecipitate specific chromatin DNA fragments. The 
sequences of the promoter specific primers are shown in supplementary table 1. 
 
Ser133Ala CREB conditional knockin mutation 
A conditional knockin mutation of Ser133 to alanine was generated using a minigene 
method similar to that described in3 and illustrated in supplementary Fig. 7A.   In 
this method a minigene (driven of the endogenous promoter) is inserted upstream of 
the mutated exon, and results in transcription of a wild type protein.  Expression of 
Cre recombinase excises the minigene due to the presence of flanking LoxP sites, and 
allows transcription of the mutated exon.  In this study, mice homozygous for the 
targeted CREB locus a Tamoxifen inducible Cre transgenic.  These mice express a 
mutated ER-Cre fusion protein that is inactive in the absence of Tamoxifen4.  
Addition of Tamoxifen to BMDMs from these mice activates the Cre resulting in 
excision of the minigene.  To determine the efficiency of excision in BMDMs, the 
CREB mRNA was subclonned and sequenced.  This showed an efficiency of 
approximately 60% (25 mutated sequences out of 41, cloned from 4 independent 
reverse transcriptions).  Primers used for PCR of CREB are given in supplementary 
table 1.  Quantitative PCR analysis using the same primers showed that the relative 
expression level of the CREB mRNA between Ser133Ala knockin and wild-type cells 
was similar indicating that the mutation did not affect CREB mRNA levels in the cell 
(JSCA, data not shown). 
 
Supplementary references 
1. Darragh, J. et al. MSKs are required for the transcription of the nuclear orphan 
receptors Nur77, Nurr1 and Nor1 downstream of MAPK signalling. Biochem 
J 390, 749-59 (2005). 
2. Saccani, S. & Natoli, G. Dynamic changes in histone H3 Lys 9 methylation 
occurring at tightly regulated inducible inflammatory genes. Genes Dev 16, 
2219-24 (2002). 
3. Bayascas, J.R., Sakamoto, K., Armit, L., Arthur, J.S. & Alessi, D.R. 
Evaluation of approaches to generation of tissue-specific knock-in mice. J Biol 
Chem 281, 28772-81 (2006). 
4. Seibler, J. et al. Rapid generation of inducible mouse mutants. Nucleic Acids 
Res 31, e12 (2003). 
 
 Supplementary table 1. Primer sequences used for PCR. 
symbol protein use Sense primer Antisense primer 
Il12a IL-12p35 q-PCR TATCTCTATGGTCAGCGTTCC TGGTCTTCAGCAGGTTTCG 
Il12b IL-12p40 q-PCR TCATCAGGGACATCATCAAACC TGAGGGAGAAGTAGGAATGGG 
Tnf TNFα q-PCR CAGACCCTCACACTCAGATCATC GGCTACAGGCTTGTCACTCG 
Il6 IL-6 q-PCR TTCCATCCAGTTGCCTTCTTG AGGTCTGTTGGGAGTGGTATC 
Il10 IL-10 q-PCR CCCTTTGCTATGGTGTCCTTTC GATCTCCCTGGTTTCTCTTCCC 
Dusp1 DUSP1 q-PCR TGGGAGCTGGTCCTTATTTATT GACTGCTTAGGAACTCAGTGGAA 
18s 18s RNA q-PCR GTAACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG 
Egr1 Egr1 q-PCR ACAGAAGGACAAGAAAGCAGAC CCAGGAGAGGAGTAGGAAGTG 
Nr4a1 Nur77 q-PCR CCTGTTGCTAGAGTCTGCCTTC CAATCCAATCACCAAAGCCACG 
Creb1 CREB q-PCR CCGGAACTCAGATTTCAACTATTGC CCTCTTCTGACTTTTCTTCTTCAATCC 
Dusp1  DUSP1 ChIP GTCTTTGCTTTTGGCTTTGG CGCGGTTTTATGTAGCCTCT 
Il10 IL-10 ChIP CAGAAGTTCATTCCGACCAGT CCTTCCTGGCAAAGGTTTTT 
Nfkbia  IκBα ChIP AAAGTTCCCTGTGCATGACC GGAATTTCCAAGCCAGTCAG 
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Supplementary Figure 1. Knockout of MSK1 and MSK2 does not affect macrophage
differentiation.
A) Bone marrow cells were differentiated into BMDMs by culturing for seven days in media
containing 5 ng/ml M-CSF. Cultured cells were stained with an antibody specific for the
macrophage marker F4/80 (black lines).  Isotype control staining is shown by the shaded
grey area.
B) As in (A), but cells were stained with an antibody specific for the dendritic cell marker
CD83 to control for dendritic cell contamination.
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Supplementary Figure 2. No difference in the production of cytokines IL-1α, IL-1β, IL-2,
IL-3, IL-4, IL-5, IL-9, IL-13 and IL-17 by wild-type and MSK1,2 knockout cells.
BMDMs from either wild-type or MSK1,2 knockout mice were stimulated with 100 ng/ml of
LPS.  Samples of the culture media were taken at 0, 4 and 12 hours after stimulation, and the
concentrations were measured by a Luminex-based assay. Error bars represent the s.e.m of three
independent stimulations.
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Supplementary Figure 3. ERK1/2 and p38 regulate TNF and IL-6 production.
A) Wild type BMDMs were pre-incubated for 1 h with either PD184352 (2 µM), SB203580 (5 µ
M) or a combination of both inhibitors as indicated.  Cells were then stimulated for 60 min
with 100 ng/ml of LPS.  Total RNA was isolated and TNF or IL-6 mRNA expression
analyzed by PCR.  Results are corrected for 18s RNA quantities, and error bars represent the
s.e.m of three independent stimulations.
B) Wild type BMDMs were pre-incubated for 1 h with either PD184352 (2 µM), SB203580 (5 µ
M) or a combination of both inhibitors as indicated.  Cells were then stimulated for 6 h with
100 ng/ml of LPS. Concentrations of secreted TNF and IL-6 were measured by a Luminex-
based assay. Error bars represent the s.e.m of three independent stimulations.
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Supplementary Figure 4. Both ERK1/2 and p38 regulate production of IL-10.
A) Wild type BMDMs were pre-incubated for 1 h with either PD184352 (2 µM), SB203580 (5 µ
M) or a combination of both inhibitors as indicated.  Cells were then stimulated for 60 min
with 100 ng/ml of LPS.  Total RNA was isolated and IL-10 mRNA expression analyzed by
PCR.  Results are corrected for 18s RNA quantities, and error bars represent the s.e.m of three
independent stimulations.
B) Wild type BMDMs were pre-incubated for 1 h with either PD184352 (2 µM), SB203580 (5 µ
M) or a combination of both inhibitors as indicated.  Cells were then stimulated for 6 h with
100 ng/ml of LPS. Concentrations of secreted IL-10 were measured by a Luminex-based assay.
Error bars represent the s.e.m of three independent stimulations.
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Supplementary Figure 5. IL-10-induced STAT3 phosphorylation is MSK-independent.
A) Wild-type BMDMs were pretreated for 15 min with either α-IL-10 or α-IL-6 neutralising
antibodies (2.5 µg/ml) where indicated.  Cells were then stimulated with either LPS (100
ng/ml, 2 or 6 h) or rmIL-10 (10 ng/ml, 30 min).  Cells were lysed and immunoblotted for
phosphorylated STAT3 (Tyr705) , total STAT3 and actin.
B) BMDMs were isolated from wild-type or MSK1,2 knockout mice and stimulated with IL-10
(10 ng/ml) for the indicated times.  Cells were lysed and immunoblotted for phosphorylated
STAT3 (Tyr705) and total STAT3.
C) Total RNA was isolated from wild-type (black bars) or MSK1,2 knockout (white bars)
following LPS stimulation for the indicated times.  SOCS3 mRNA quantities were
determined using 18s RNA as a loading control by quantitative-PCR.  Error bars represent
the s.e.m. of 6 stimulations.
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Supplementary Figure 6.  IL-10 production is not affected by IL-10- neutralizing antibodies.
A) BMDMs were pre-treated for 15 min with anti-IL10 (2.5 µg/ml) or rat IgG (2.5 µg/ml) as
indicated. Cells were stimulated with 100 ng/ml of LPS for 8 h.  Cells were lysed and total
mRNA was isolated.  IL-10 mRNA quantities were determined by PCR. Samples were
corrected for expression of 18s RNA and fold induction calculated relative to the wild type
zero time point. Error bars represent the s.e.m of three independent stimulations.
B) As in (A) except concentrations of IL-10 secreted into the media were measured by a
Luminex-based assay. Error bars represent the s.e.m of three independent stimulations.
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Supplementary Figure 7. Ser133Ala CREB knockin BMDMs
A) To create a conditional CREB Ser133Ala allele, a CREB minigene (blue) and a mutated version on
exon 4 (containing the Ser133Ala mutation) were introduced in place of exon 4 of the endogenous CREB
gene using conventional gene targeting techniques.  The minigene contained a wild type exon 4 sequence
fused to the 3’ exons of the CREB gene.  To allow selection in embryonic stem cells, it was followed by a
PGK-neomycin cassette.  Both the CREB minigene and neo were followed by polyadenylation sequences
to terminate transcription.  To allow excision, the mini gene was flanked by loxP sites (green triangles).
Predicted splicing is shown by grey lines.  In the targeted allele, splicing should occur onto the minigene,
resulting in a wild type protein.  Following expression of Cre, the minigene is removed allowing splicing
onto the mutated exon 4 and transcription of the Ser133Ala mutant.  To achieve deletion in macrophage
culture, mice were crossed on to a tamoxifen inducible CRE transgenic background.
B) BMDMs were isolated from wild type (black bars) and CREB Ser133Ala knockin (grey bars) mice.
Both cultures were treated with 0.1 µM Tamoxifen from day 5 to 7 of differentiation.  Macrophages were
then replated in Tamoxifen free media and used 24 h later.  Cells were stimulated for 1 hour with 100
ng/ml LPS or left unstimulated. Total RNA was isolated and the quantities the CREB independent gene
egr1, as well as TNFα and IL-6 were determined by quantitative-PCR.  18s RNA was used as a loading
control and fold induction calculated relative to wild-type control values.  Error bars represent the s.e.m of
4 stimulations.
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Supplementary Figure 8. Plasma cytokine concentrations following an i.p. injection of LPS.
Wild-type (black bars) and MSK1,2 knockout (white bars) mice were given an i.p. injection of either
saline control (c) or 1.8 mg/kg of LPS for 1 h or 4 h.  Mice were sacrificed and blood taken by cardiac
puncture.  Plasma cytokine concentrations were measured by a Luminex-based assay.  Error bars
represent the s.e.m of 6 mice.
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Supplementary Figure 9. Tamoxifen CRE does not affect LPS-induced CREB
phosphorylation or cytokine transcription.
A) BMDMs were isolated from wild type (black bars) and Tamoxifen-CRE (grey bars) mice.
Both cultures were treated with 0.1 µM Tamoxifen from day 5 to 7 of differentiation.
Macrophages were then replated in Tamoxifen free media and used 24 h later.  Cells were
stimulated for 1 hour with 100 ng/ml LPS or left unstimulated. Total RNA was isolated and
the quantities of IL-10, DUSP1, IL-6 and TNFα were determined by quantitative-PCR.  18s
was used as a loading control and fold stimulation calculated relative to wild type control
values.  Error bars represent the s.e.m of 4 stimulations.
B) As (A) except that cells were stimulated for 15 or 30 min with LPS and then lysed into SDS
sample buffer.  Levels of phosphorylated CREB (Ser133) and total CREB were determined
by immunoblotting
A
B
0 15 30 0 15 30
200
100
Con LPS
0
150
100
75
Con LPS
0
1200
600
Con LPS
0
800
400
Con LPS
0
WT
TamoxCRE
